Human papillomavirus and cervical cancer

KS Okunade - Journal of Obstetrics and Gynaecology, 2020 - Taylor & Francis
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical
cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) …

Global cancer in women: burden and trends

LA Torre, F Islami, RL Siegel, EM Ward… - … , biomarkers & prevention, 2017 - AACR
This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

[HTML][HTML] 2020 WHO classification of female genital tumors

AK Höhn, CE Brambs, GGR Hiller… - Geburtshilfe und …, 2021 - thieme-connect.com
In der WHO-Klassifikation 2020 steht die Unterscheidung von HPV-assoziierten und HPV-
unabhängigen Plattenepithelkarzinomen des unteren weiblichen Genitales im Vordergrund …

[HTML][HTML] Human papillomavirus vaccines: an updated review

L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

[HTML][HTML] The projected timeframe until cervical cancer elimination in Australia: a modelling study

MT Hall, KT Simms, JB Lew, MA Smith… - The Lancet Public …, 2019 - thelancet.com
Summary Background In 2007, Australia was one of the first countries to introduce a national
human papillomavirus (HPV) vaccination programme, and it has since achieved high …

Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years

S Lin, K Gao, S Gu, L You, S Qian, M Tang, J Wang… - Cancer, 2021 - Wiley Online Library
Background Cervical cancer is 1 of the most common cancers in females worldwide.
Understanding the most recent global patterns and temporal trends of cervical cancer …

[HTML][HTML] Key molecular events in cervical cancer development

SD Balasubramaniam, V Balakrishnan, CE Oon… - Medicina, 2019 - mdpi.com
Cervical cancer is the fourth most common cancer among women. Infection by high-risk
human papillomavirus (HPV) is the main aetiology for the development of cervical cancer …

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines

M Saraiya, ER Unger, TD Thompson… - Journal of the …, 2015 - academic.oup.com
Background: This study sought to determine the prevaccine type-specific prevalence of
human papillomavirus (HPV)–associated cancers in the United States to evaluate the …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

WK Huh, KA Ault, D Chelmow, DD Davey… - Journal of lower …, 2015 - journals.lww.com
In 2011, the American Cancer Society, the American Society for Colposcopy and Cervical
Pathology, and the American Society for Clinical Pathology updated screening guidelines …